Randall S. Edson, MD, Robert H. Brey, PHD, Thomas J

Slides:



Advertisements
Similar presentations
My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI:
Advertisements

Celebrating the Sesquicentennial of Mayo Clinic: 150 Years of Advances in Medical Practice, Education, Research, and Professionalism  William L. Lanier,
Hearing Loss and Hearing Aid Treatment Options
Rehabilitation in Multiple Sclerosis
J. Eric Ahlskog, PhD, MD  Mayo Clinic Proceedings 
Evaluation of Proteinuria
Cogan's Syndrome: 18 Cases and a Review of the Literature
Hearing Loss and Hearing Aid Treatment Options
Robert M. Jacobson, MD, George J. Isham, MD, MS, Lila J
César A. Galván, MD, Juan Carlos Guarderas, MD  Mayo Clinic Proceedings 
William L. Lanier, MD  Mayo Clinic Proceedings 
Diagnosis and Management of Chronic Kidney Disease
Increasing Cardiac Rehabilitation Participation From 20% to 70%: A Road Map From the Million Hearts Cardiac Rehabilitation Collaborative  Philip A. Ades,
Treatment of Alcohol Withdrawal in Hospitalized Patients
Survey of Physician Leadership and Management Education
Commonly Asked Questions About Thyroid Function
Peripheral Arterial Disease: Diagnosis and Management
Corticosteroids in the Treatment of Alcohol-Induced Rhabdomyolysis
Atrial Flutter Simulated by a Portable Compact Disk Player
Obstructive Sleep Apnea and Cardiovascular Disease
George Dailey, MD  Mayo Clinic Proceedings 
Understanding Palliative Care and Hospice
Circumcision Rates in the United States: Rising or Falling
Palliative Care and Hospice Programs
Acupuncture Mayo Clinic Proceedings
Impact of the FDA Black Box Warning on Physician Antidepressant Prescribing and Practice Patterns: Opening Pandora's Suicide Box  Timothy W. Lineberry,
Subjective hearing loss and history of traumatic brain injury exhibits abnormal brainstem auditory evoked response: A case report  Brian J. Fligor, MS,
Hyperactive tendon reflexes in spastic multiple sclerosis: Measures and mechanisms of action  Li-Qun Zhang, PhD, Guangzhi Wang, MS, Takashi Nishida, MD,
Photodynamic Therapy for Early Stage Central Type of Lung Cancer
Pancreatic Ductal Adenocarcinoma
Gray-Blue Sclerae and Osteopenia Secondary to Osteogenesis Imperfecta
Ayalew Tefferi, MD  Mayo Clinic Proceedings 
Kristine M. Thompson, MD, Kristi M. Swanson, MS, Debra L
Troponin T as a Predictor of End-Stage Renal Disease and All-Cause Death in African Americans and Whites From Hypertensive Families  LaTonya J. Hickson,
The Red Scalp Sign Mayo Clinic Proceedings
Gary L. Grunkemeier, PhD, Ruyun Jin, MD, Albert Starr, MD 
Treating Tobacco Dependence in Light of the 2008 US Department of Health and Human Services Clinical Practice Guideline  J. Taylor Hays, MD, Jon O. Ebbert,
Refurbishing Mayo Clinic Proceedings:
Antidepressants and Brain Neurochemistry
Acquired Binocular Horizontal Diplopia
Greg Schwartz, Sam Taylor, Clark Fisher, Rob Harris, Michael J. Berry 
Flow-Mediated Slowing as a Methodological Alternative to the Conventional Echo- Tracking Flow-Mediated Dilation Technique for the Evaluation of Endothelial.
Renal Pyelocalyceal Squamous Cell Carcinoma
Evaluation and Management of Penicillin Allergy
Osteoporosis Associated With Megestrol Acetate
Kenneth N. Huynh, BS, Ba D. Nguyen, MD  Mayo Clinic Proceedings 
Institutional Review Boards: What Clinician Researchers Need to Know
Diabetic Mastopathy Mayo Clinic Proceedings
Simon M. Glynn, MD, Sean J. Pittock, MD, Steven A. Vernino, MD, PhD 
Allen D. Seftel, MD, Martin Kathrins, MD, Craig Niederberger, MD 
Hepatocellular Carcinoma
Methylphenidate: Its Pharmacology and Uses
Celebrating the Sesquicentennial of Mayo Clinic: 150 Years of Advances in Medical Practice, Education, Research, and Professionalism  William L. Lanier,
Medical Treatment of Overactive Bladder: In Response
Lowering the High Cost of Cancer Drugs—IV
Ross Arena, PhD, PT, FAHA, Carl J. Lavie, MD  Mayo Clinic Proceedings 
Hassanali H. Sewani, MD, Jeffrey T. Rabatin, MD 
Pulmonary Infarction Manifesting as a Cavitary Lesion
Thanh G. Phan, MD, FRACP, William E. Krauss, MD, Robert D. Fealey, MD 
Dementia and Cerebrovascular Disease
Squamous Cell Carcinoma of the Tongue
Preoperative Smoking Cessation: The Role of the Primary Care Provider
Medical Student Distress: Causes, Consequences, and Proposed Solutions
37-Year-Old Man With Painful Foot
Autonomic Tone and Benefits of Cardiac Rehabilitation Programs
Guru Sonpavde, MD, Teresa G. Hayes, MD  Mayo Clinic Proceedings 
The Potential of Medicare Accountable Care Organizations to Transform the American Health Care Marketplace: Rhetoric and Reality  David J. Ballard, MD,
21st Century Women's Health
Mayo Clinic Proceedings 2012: “A New Era in Journal Stewardship”
PATRICIA A. PELLIKKA, M. D. , THOMAS BEHRENBECK, M. D. , KENNETH C
Presentation transcript:

Vestibular Toxicity Due to Inhaled Tobramycin in a Patient With Renal Insufficiency  Randall S. Edson, MD, Robert H. Brey, PHD, Thomas J. McDonald, MD, Christine L. Terrell, MD, James T. McCarthy, MD, Janet M. Thibert, MS  Mayo Clinic Proceedings  Volume 79, Issue 9, Pages 1185-1191 (September 2004) DOI: 10.4065/79.9.1185 Copyright © 2004 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 1 Pure-tone air-conduction hearing threshold tests (American National Standards Institute [ANSI] 1996 standards). “O” represents thresholds for the right ear and “X” thresholds for the left ear. Left, July 1999 measurement. Right, August 2002 measurement. Mayo Clinic Proceedings 2004 79, 1185-1191DOI: (10.4065/79.9.1185) Copyright © 2004 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 2 Results of smooth ocular pursuit testing. Top, Bottom panel shows mean velocity gain values measured in July 1999 (black circles) for smooth ocular pursuit from 0.2 to 0.7 Hz compared with normal values (shaded area is abnormal). Upper panel shows tracking signal for 0.71 Hz (solid smooth sine wave between the vertical lines) compared with patient's response (cogwheeling line). Right gain was 0.5, left gain was 0.66, and phase shift was -12.7°. Bottom, lower panel shows mean velocity gain values measured in August 2002 (black squares) for smooth ocular pursuit from 0.2 to 0.7 Hz compared with normal values (shaded area is abnormal). Upper panel shows tracking signal for 0.6 Hz (between the vertical lines) compared with patient's response. Note that cogwheeling seen in 1999 has resolved in 2002. Right gain was 0.65, left gain was 0.8, and phase shift was -3.2°. H = patient's horizontal pursuit; L = left; R = right; ST = stimulus. Mayo Clinic Proceedings 2004 79, 1185-1191DOI: (10.4065/79.9.1185) Copyright © 2004 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 3 Top, Alternating bithermal binaural caloric testing in July 1999 revealed peak slow-phase velocities (SPV) of 7, -13, -12, and 12 for right cool, right warm, left cool, and left warm, respectively. Bottom, Testing in August 2002 revealed SPV of 12, -21, -11, and 21 for right cool, right warm, left cool, and left warm, respectively. (Note scale difference between top [0-20° per second] and bottom [0-40° per second].) Boxes represent a 10-second window used to calculate peak SPV. Deg/sec = degrees per second. Mayo Clinic Proceedings 2004 79, 1185-1191DOI: (10.4065/79.9.1185) Copyright © 2004 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 4 Sensory organization testing in July 1999 (top) and August 2002 (bottom). Sensory organization test (SOT) condition 1 = eyes open and wall and platform fixed; SOT 2 = eyes closed and wall and platform fixed; SOT 3 = eyes open, wall sway-referenced relative to the patient's sway, and platform fixed; SOT 4 = eyes open, wall fixed, and platform sway-referenced relative to the patient's sway; SOT 5 = eyes closed and platform sway-referenced relative to the patient's sway; SOT 6 = eyes open and wall and platform sway-referenced relative to the patient's sway. Three trials are conducted for each SOT condition. Shaded area is abnormal. The vertical text “FALL” indicates that the patient touched the wall or had to move her feet to avoid falling. Mayo Clinic Proceedings 2004 79, 1185-1191DOI: (10.4065/79.9.1185) Copyright © 2004 Mayo Foundation for Medical Education and Research Terms and Conditions